BNP PARIBAS FINANCIAL MARKETS

Holdings History for Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Symbol: SRPT on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.01%	0%	$15,661,955	727,786	0		$21.52	Q4 2025
30 Sep 2025		0.03%	0%	$34,326,576	1,781,348	0		$19.27	Q3 2025
30 Jun 2025		0.02%	0%	$21,097,108	1,233,749	0		$17.10	Q2 2025
30 Jun 2025	put		0%	$684,000	400	0		$1710.00 ^*	Q2 2025
31 Mar 2025		0%	0%	$2,170,391	34,008	0		$63.82	Q1 2025
31 Dec 2024		0%	0%	$3,337,402	27,448	0		$121.59	Q4 2024
31 Dec 2024	put		0%	$121,590	10	0		$12159.00 ^*	Q4 2024
30 Sep 2024		0%	0%	$3,413,369	27,331	0		$124.89	Q3 2024
30 Jun 2024		0.01%	0%	$11,822,508	74,826	0		$158.00	Q2 2024
31 Mar 2024		0.04%	0%	$29,177,954	225,382	0		$129.46	Q1 2024
31 Dec 2023		0.03%	0%	$14,312,719	148,426	0		$96.43	Q4 2023
30 Sep 2023		0.01%	0%	$3,664,481	30,230	0		$121.22	Q3 2023
30 Jun 2023		0%	0%	$2,339,071	20,425	0		$114.52	Q2 2023
31 Mar 2023		0.05%	0%	$21,915,108	159,001	0		$137.83	Q1 2023
31 Dec 2022		0.01%	0%	$4,869,228	37,577	0		$129.58	Q4 2022
30 Jun 2022		0.01%	0%	$5,226,511	69,724	0		$74.96	Q2 2022
31 Mar 2022		0.02%	0%	$10,230,048	130,953	0		$78.12	Q1 2022
31 Dec 2021		0.03%	0%	$12,931,990	143,609	0		$90.05	Q4 2021
30 Sep 2021		0.01%	0%	$5,639,800	60,984	0		$92.48	Q3 2021
30 Jun 2021		0.01%	0%	$2,857,023	36,751	0		$77.74	Q2 2021
31 Mar 2021		0.01%	0%	$3,238,254	43,449	0		$74.53	Q1 2021
31 Dec 2020		0.02%	0%	$4,519,690	26,510	0		$170.49	Q4 2020
30 Sep 2020		0.01%	0%	$3,370,460	24,001	0		$140.43	Q3 2020
30 Jun 2020		0.01%	0%	$5,348,141	33,355	0		$160.34	Q2 2020
31 Mar 2020		0.01%	0%	$3,783,188	38,675	0		$97.82	Q1 2020
31 Dec 2019		0.01%	0%	$3,588,990	27,813	0		$129.04	Q4 2019
30 Sep 2019		0.01%	0%	$1,812,425	24,063	0		$75.32	Q3 2019
30 Jun 2019		0%	0%	$1,137,954	7,489	0		$151.95	Q2 2019
31 Mar 2019		0%	0%	$318,952	2,676	0		$119.19	Q1 2019
31 Dec 2018		0%	0%	$281,337	2,578	0		$109.13	Q4 2018
30 Sep 2018		0%	0%	$1,198,889	7,423	0		$161.51	Q3 2018
30 Jun 2018		0%	0%	$293,440	2,220	0		$132.18	Q2 2018
31 Mar 2018		0%	+0%	$1,302,650	17,582	+1,907	+12%	$74.09	Q1 2018
31 Dec 2017		0%	+0%	$872,157	15,675	+8,883	+131%	$55.64	Q4 2017
30 Sep 2017		0%	+0%	$308,085	6,792	+303	+4.7%	$45.36	Q3 2017
30 Jun 2017		0%	+0%	$218,744	6,489	+5,306	+449%	$33.71	Q2 2017
31 Mar 2017		0%	-0%	$35,017	1,183	-721	-38%	$29.60	Q1 2017
31 Dec 2016		0%	-0%	$52,227	1,904	-1,637	-46%	$27.43	Q4 2016
30 Sep 2016		0%	+0%	$217,453	3,541	+1,886	+114%	$61.41	Q3 2016
30 Jun 2016		0%	+0%	$31,561	1,655	+1,655	NEW	$19.07	Q2 2016
31 Mar 2016			-0%	$0	0	-4,780	-100%	$18.50	Q1 2016
31 Dec 2015		0%	-0%	$184,412	4,780	-3,838	-45%	$38.58	Q4 2015
30 Sep 2015		0%	+0%	$276,724	8,618	+5,169	+150%	$32.11	Q3 2015
30 Jun 2015		0%	+0%	$104,953	3,449	+2,475	+254%	$30.43	Q2 2015
31 Mar 2015		0%	+0%	$12,935	974	+974	NEW	$13.28	Q1 2015
31 Dec 2014			-0%	$0	0	-2,345	-100%	$18.50	Q4 2014
30 Sep 2014		0%	+0%	$49,480	2,345	+2,345	NEW	$21.10	Q3 2014
31 Mar 2014			-0%	$0	0	-435	-100%	$18.50	Q1 2014
31 Dec 2013		0%	0%	$8,861	435	0		$20.37	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.